Toyohara Jun, Vugts Danielle, Kiss Oliver C, Todde Sergio, Li Xiang-Guo, Liu Zhibo, Yang Zhi, Gillings Nic, Cazzola Emiliano, Szymanski Wiktor, Meulen Nick van der, Reilly Raymond, Taddei Carlotta, Schirrmacher Ralf, Li Zijing, Lagebo Yohannes Jorge, Bentaleb Naoual, Souza Albernaz Marta de, Lapi Suzanne, Ramogida Caterina, Mukherjee Archana, Ajenjo Javier, Deuther-Conrad Winnie, Bourdeau Cécile
Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
Amsterdam University Medical Center, Amsterdam, The Netherlands.
EJNMMI Radiopharm Chem. 2024 May 16;9(1):42. doi: 10.1186/s41181-024-00268-w.
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.
Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
《EJNMMI放射药学与化学》编辑委员会每半年发布一次重点评论，向读者介绍放射性药物开发领域的趋势。
本重点内容选集对每位共同撰写的编辑委员会成员选择的24个不同主题进行了评论，涉及从新型放射化学到新型放射性药物首次人体应用等各个方面。
强调了放射化学和放射药学的趋势。热门话题涵盖了《EJNMMI放射药学与化学》的整个范围，展示了该研究领域在许多方面的进展。
